AzTrials
AzTrials

Suicidal IdeationNCT05816317

Randomized Controlled Trial of a Single-session Mechanism-focused Intervention for Suicidal Thoughts and Behaviors

A study testing Single-Session Mechanism-Focused Intervention (SSMFI) and Distress Tolerance Skills Review in people with Suicidal Ideation and Hopelessness, run by Shannon E. Sauer-Zavala at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Across multiple models of suicide risk, hopelessness and perceptions of social relatedness (i.e., lack of social connection/thwarted belongingness, perceived burdensomeness) have emerged as candidate mechanisms that maintain STBs. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Suicidal Ideation, Hopelessness, Wish to Live
What is being tested?
Single-Session Mechanism-Focused Intervention (SSMFI) and Distress Tolerance Skills Review
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteUnited States
Study dates
16 Oct 2024to 20 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • admitted for care to the Adult Inpatient Unit at Good Samaritan Hospital
  • endorse suicidal ideation and/or a recent suicide attempt (i.e., "a potentially self-injurious act committed with at least some wish to die") upon intake to the unit
  • 18 years of age; (4) English speaking
  • able to provide two methods for follow-up contact (i.e., phone number, email address) in order to complete study follow-up assessment.

Who cannot join

  • current manic episode
  • acutely psychotic
  • actively detoxicating from substances
  • the inability to comprehend the intervention

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Kentucky

    Lexington, Kentucky, 40506

Other trials in United States

About this study

Official title: A Single-session Intervention for Suicidal Thoughts and Behaviors

Across multiple models of suicide risk, hopelessness and perceptions of social relatedness (i.e., lack of social connection/thwarted belongingness, perceived burdensomeness) have emerged as candidate mechanisms that maintain STBs. Although these mechanisms have garnered strong empirical support in predicting STBs, there has been virtually no integration with interventions aimed for individuals at acute risk for suicide. Thus, the overarching goal of the present proposal is to evaluate a mechanism-focused intervention that explicitly targets two core mechanisms implicated in the maintenance of STBs: hopelessness and negative perceptions of social relatedness. Given that the period immediately following hospital discharge presents the highest risk for suicide attempts and up to 70% of patients admitted for a suicide attempt do not attend their first outpatient appointment, the intervention will be evaluated on an inpatient unit. Additionally, most of the extant interventions for STBs are administered across multiple sessions (i.e., 4 sessions and up to one year); however treatments of this length are unlikely to be feasible in acute care settings. Fortunately, very brief suicide prevention interventions, are effective in reducing future suicide attempts and increasing the likelihood of attending follow-up treatments. Additionally, single-session interventions (not suicide specific) have been shown to reduce hopelessness immediately and at a one-month follow-up.

The present study is an RCT comparing a novel Single Session Mechanism Focused Intervention (SSMFI) for STBs to treatment-as-usual (TAU) on a psychiatric inpatient unit for patients admitted for suicidal ideation or attempt. The engagement of the putative processes (hopelessness and negative perceptions of social relatedness) that maintain STBs will be assessed, along with the feasibility and acceptability of SSMFI for STBs on an inpatient psychiatric unit.

Being tested
Single-Session Mechanism-Focused Intervention (SSMFI), Distress Tolerance Skills Review
Medical subject headings
Suicidal Ideation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Single-Session Mechanism-Focused Intervention (SSMFI)Behavioural

    A brief intervention for patients hospitalized for suicide risk that directly targets hopelessness and perceptions of social relatedness.

  • Distress Tolerance Skills ReviewBehavioural

    Treatment as usual at the inpatient setting for this study.

Study groups in NCT05816317
Study groupRoleWhat they receive
Single-Session Mechanism Focused Intervention (SSMFI)ExperimentalNot described
Receives: Behavioral: Single-Session Mechanism-Focused Intervention (SSMFI)
Treatment as UsualActive comparatorNot described
Receives: Behavioral: Distress Tolerance Skills Review

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in intensity of suicidal ideation

    RATE OVERALL INTENSITY OF YOUR SUICIDAL IDEATION RIGHT NOW: (scale from "1" Extremely low intensity to "5" Extremely high intensity)

    Measured: Pre-intervention and directly after the intervention (i.e., 1 hour later)

  2. Change in hopelessness

    How much are you feeling hopeless right now? (scale from "1" Not at all to "5" A lot)

    Measured: Pre-intervention and directly after the intervention (i.e., 1 hour later)

  3. Change in wish to live

    I wish to live this much: (scale from "0" Not at all to "8" Very much)

    Measured: Pre-intervention and directly after the intervention (i.e., 1 hour later)

  4. Change in wish to die

    I wish to die this much: (scale from "0" Not at all to "8" Very much)

    Measured: Pre-intervention and directly after the intervention (i.e., 1 hour later)

  5. Change in Beck Hopelessness Scale

    Hopelessness will be measured with the Beck Hopelessness Scale. Scores range from 0-20 and higher scores indicate greater levels of hopelessness.

    Measured: pre-intervention, 1 week after the intervention is completed, 1 month after the intervention is completed

  6. Change in Interpersonal Needs Questionnaire

    Perceptions of social connectedness will be assessed with the Interpersonal Needs Questionnaire. Scores range from 0 to 107 with higher scores indicating less connection with others.

    Measured: pre-intervention, 1 week after the intervention is completed, 1 month after the intervention is completed

Secondary outcomes (2)
  1. Change in Columbia Suicide Severity Rating Scale

    The self-report version of the Columbia Suicide Severity Rating Scale will be used to assess the presence of suicidal behaviors thoughts and behaviors. Participants are asked to respond Yes/No to 6 items that refer to various suicide related phenomena (thoughts, planning, intent, and behaviors). There is no total score for this measure.

    Measured: pre-intervention, 1 week after the intervention is completed, 1 month after the intervention is completed

  2. Change in Adult Suicidal Ideation Questionnaire

    Intensity of suicidal ideation will be measured with the Adult Suicidal Ideation Questionnaire. Scores range from 0-150 and higher scores indicate greater intensity of suicidal ideation.

    Measured: pre-intervention, 1 week after the intervention is completed, 1 month after the intervention is completed

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Apr 2023
  2. Study start16 Oct 2024
  3. Primary completion20 May 2025
  4. Study completion20 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05816317
Sponsor's protocol ID
343205
Status last verified
Jul 2025
First submitted
29 Mar 2023
Last updated
1 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Single-Session Mechanism-Focused Intervention (SSMFI) and Distress Tolerance Skills Review in people with Suicidal Ideation and Hopelessness, run by Shannon E. Sauer-Zavala at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in intensity of suicidal ideation (time frame: Pre-intervention and directly after the intervention (i.e., 1 hour later)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in